Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Neomycin, also known as framycetin, is an aminoglycoside antibiotic that displays bactericidal activity against Gram-negative aerobic bacilli and some anaerobic bacilli where resistance has not yet arisen. It is generally not effective against Gram-positive bacilli and anaerobic Gram-negative bacilli. Neomycin comes in oral and topical formulations…
Applications, Medical uses & Mechanism of action
Explore the main themes, entities and connections around Neomycin. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
also topical aminoglycosides gram-negative used activity antibiotic bacteria known university oral dna aminoglycoside ribostamycin binding cell gene one effective use
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Neomycin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Neomycin | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Neomycin | ATC code | A01AB08 (WHO) A07AA01 (WHO), B05CA09 (WHO), D06AX04 (WHO), J01GB05 (WHO), R02AB01 (WHO), S01AA03 (WHO), S02AA07 (WHO), S03AA01 (WHO) | 1.00 | infobox |
| Neomycin | Bioavailability | < 3% (oral) | 1.00 | infobox |
| Neomycin | CAS Number | 1404-04-2 Y | 1.00 | infobox |
| Neomycin | ChEBI | CHEBI:7508 Y | 1.00 | infobox |
| Neomycin | ChEMBL | ChEMBL449118 N | 1.00 | infobox |
| Neomycin | ChemSpider | 8075 Y | 1.00 | infobox |
| Neomycin | DrugBank | DB00994 Y | 1.00 | infobox |
| Neomycin | ECHA InfoCard | 100.014.333 | 1.00 | infobox |
| Neomycin | Elimination half-life | 2 to 3 hours | 1.00 | infobox |
| Neomycin | Formula | C23H46N6O13 | 1.00 | infobox |
| Neomycin | IUPHAR/BPS | 709 | 1.00 | infobox |
| Neomycin | KEGG | D08260 Y | 1.00 | infobox |
| Neomycin | Legal status | US: ℞-only but OTC in Neosporin and similar ointments | 1.00 | infobox |
| Neomycin | MedlinePlus | a682274 | 1.00 | infobox |
| Neomycin | Metabolism | (Not used systemically) | 1.00 | infobox |
| Neomycin | Molar mass | 614.650 g·mol−1 | 1.00 | infobox |
| Neomycin | Protein binding | (Not used systemically) | 1.00 | infobox |
| Neomycin | PubChem CID | 8378 | 1.00 | infobox |
| Neomycin | Routes of administration | Topical, oral | 1.00 | infobox |
| Neomycin | Trade names | Neo-rx | 1.00 | infobox |
| Neomycin | UNII | I16QD7X297 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.